Small pharmaceutical companies are delivering the good news one after the other
Small pharmaceutical companies are delivering the good news one after the other.
First, KoreaPharma stepped closer to the development of treatment for dementia. On July 29, KoreaPharma signed a technology transfer agreement regarding development • co-research of new dementia treatment with Gyeon...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
